Evidence map›Paper›PMID 30975139›Full record

ArticleHarm reduction journal2019

Understanding hepatitis B, hepatitis C and HIV among people who inject drugs in South Africa: findings from a three-city cross-sectional survey.

Andrew Scheibe, Katherine Young, Lorraine Moses, Rudolph L Basson, Anna Versfeld, C Wendy Spearman, Mark W Sonderup, Nishi Prabdial-Sing, Jack Manamela, Adrian J Puren and 2 more

Abstract read
In one paragraph

Article in Harm reduction journal, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Retention of service users on opioid substitution therapy in the City of Tshwane, South Africa.African journal of primary health care & family medicine · 2023
    Article
  17. Article
  18. Article
  19. Managing acute opioid withdrawal with tramadol during COVID-19 lockdown in a peri-urban setting.African journal of primary health care & family medicine · 2022
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Andrew ScheibeTB HIV Care, 11 Adderley Street, Cape Town, South Africa. andrew.scheibe@gmail.com.ORCID 0000-0002-3238-0699
Katherine YoungTB HIV Care, 11 Adderley Street, Cape Town, South Africa.
Lorraine MosesIQVIA South Africa, CX Building 1021 Lenchen Ave North, Centurion, Pretoria, South Africa.
Rudolph L BassonTB HIV Care, 11 Adderley Street, Cape Town, South Africa.
Anna VersfeldTB HIV Care, 11 Adderley Street, Cape Town, South Africa.
C Wendy SpearmanDivision of Hepatology, Department of Medicine, Faculty of Health Sciences, University of Cape Town, Old Main Building, Groote Schuur Hospital, Observatory, Cape Town, South Africa.
Mark W SonderupDivision of Hepatology, Department of Medicine, Faculty of Health Sciences, University of Cape Town, Old Main Building, Groote Schuur Hospital, Observatory, Cape Town, South Africa.
Nishi Prabdial-SingNational Institute for Communicable Diseases, 1 Modderfontein Road, Sandringham, Johannesburg, South Africa.
Jack ManamelaNational Institute for Communicable Diseases, 1 Modderfontein Road, Sandringham, Johannesburg, South Africa.
Adrian J PurenNational Institute for Communicable Diseases, 1 Modderfontein Road, Sandringham, Johannesburg, South Africa.
Kevin RebeDivision of Virology, School of Pathology, University of the Witwatersrand, Johannesburg, South Africa.
Harry HauslerTB HIV Care, 11 Adderley Street, Cape Town, South Africa.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPeople who inject drugs (PWID) are at high risk for hepatitis C (HCV), hepatitis B (HBV) and HIV without accessible harm reduction programmes. Coverage of needle and syringe and opioid substitution therapy (OST) services in South Africa is below global recommendations and no hepatitis services exist for PWID. We assessed HCV, HBV and HIV prevalence and risk factors among PWID accessing harm reduction services in Cape Town, Durban and Pretoria to inform policy and programming.

methodsWe conducted a cross-sectional survey among PWID in these cities between August 2016 and October 2017. Participants were opportunistically sampled while accessing services. Study team members administered a questionnaire that assessed sociodemographic characteristics, drug use and sexual risk practices. We tested for HCV (antibody, viral load and genotype), HBV surface antigen (HBsAg) and HIV. Bivariate and multivariate analyses assessed associations with HCV serostatus.

resultsNine hundred and forty-three PWID were included in the per protocol analysis. The majority (87%, 819/943) were male, the overall median age was 29 and most lived on the street (66%, 626/943). At last injection, 77% (722/943) reported using a new needle and syringe and 17% (163/943) shared equipment. HIV prevalence was 21% (196/926), HBsAg positivity 5% (47/936), HCV seroprevalence 55% (513/937), HCV viraemic prevalence (proportion tested with detectable HCV) 43% (404/937) and HCV viraemic rate (proportion HCV antibody positive with detectable HCV) 79% (404/513). HCV genotype 1a (73%, 270/368) was the most prevalent. In multivariate analysis, HCV infection was positively associated with residing in Pretoria (adjusted odds ratio (aOR) 1.27, 95% CI 1.21-1.34), living on the street (aOR 1.90, 95% CI 1.38-2.60), frequent injecting (aOR 1.58, 95% CI 1.15-2.16) and HIV infection (aOR 1.69, 95% CI 1.15-2.47), and negatively associated with black race (aOR 0.52, 95% CI 0.36-0.74) and sexual activity in the previous month (aOR 0.61, 95% CI 0.42-0.88).

conclusionsHCV and HIV are major health threats affecting PWID in these cities. Access to OST and needle and syringe services needs to be increased and integrated with HCV services. Social and structural factors affecting PWID who live on the street need to be addressed.

Indexed as

AdultAmphetamine-Related DisordersCondomsCross-Sectional StudiesFemaleHarm ReductionHealth PolicyHepatitis B, ChronicHepatitis B Surface AntigensHepatitis C AntibodiesHepatitis C, ChronicHeroin DependenceHIV InfectionsHIV SeroprevalenceHumansIll-Housed PersonsHepatitis B Surface AntigensHepatitis C AntibodiesHBVHCVHepatitis BHepatitis CHIVKey populationsPeople who inject drugsSouth Africa

Identifiers

PMID30975139
PMCPMC6460775

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.